Prestige Biopharma Designated as a Non-Compliant Disclosure Corporation
[Asia Economy Reporter Gong Byung-sun] Prestige Biopharma announced on the 6th that it has been designated as a non-compliant disclosure corporation by the Korea Exchange's KOSPI Market Division.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- President Lee Orders Thorough Investigation and Safety Inspection of Rebar Omission in GTX-A Samsung Station Section
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The reason for the non-compliant disclosure designation is the delayed disclosure of information related to the signing of a comprehensive contract for pharmaceutical contract manufacturing. The penalty for the disclosure violation is 16 million KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing 90 Degrees These Days Actually Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
